146 related articles for article (PubMed ID: 31096038)
1. Candidiasis associated with very early onset inflammatory bowel disease: First IL10RB deficient case from the National Iranian Registry and review of the literature.
Yazdani R; Moazzami B; Madani SP; Behniafard N; Azizi G; Aflatoonian M; Abolhassani H; Aghamohammadi A
Clin Immunol; 2019 Aug; 205():35-42. PubMed ID: 31096038
[TBL] [Abstract][Full Text] [Related]
2. Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children.
Nemati S; Teimourian S; Tabrizi M; Najafi M; Dara N; Imanzadeh F; Ahmadi M; Aghdam MK; Tavassoli M; Rohani P; Madani SR; de Boer M; Kuijpers TW; Roos D
Eur J Med Genet; 2017 Dec; 60(12):643-649. PubMed ID: 28864178
[TBL] [Abstract][Full Text] [Related]
3. Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.
Huang Z; Peng K; Li X; Zhao R; You J; Cheng X; Wang Z; Wang Y; Wu B; Wang H; Zeng H; Yu Z; Zheng C; Wang Y; Huang Y
Inflamm Bowel Dis; 2017 Apr; 23(4):578-590. PubMed ID: 28267044
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of interleukin 10 receptor gene mutations in children with very early-onset inflammatory bowel disease.
Beser OF; Conde CD; Serwas NK; Cokugras FC; Kutlu T; Boztug K; Erkan T
J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):332-8. PubMed ID: 25373860
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.
Zheng C; Huang Y; Hu W; Shi J; Ye Z; Qian X; Huang Z; Xue A; Wang Y; Lu J; Tang Z; Wu J; Wang L; Peng K; Zhou Y; Miao S; Sun H
Inflamm Bowel Dis; 2019 Mar; 25(4):756-766. PubMed ID: 30212871
[TBL] [Abstract][Full Text] [Related]
6. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis.
Moran CJ; Walters TD; Guo CH; Kugathasan S; Klein C; Turner D; Wolters VM; Bandsma RH; Mouzaki M; Zachos M; Langer JC; Cutz E; Benseler SM; Roifman CM; Silverberg MS; Griffiths AM; Snapper SB; Muise AM
Inflamm Bowel Dis; 2013 Jan; 19(1):115-23. PubMed ID: 22550014
[TBL] [Abstract][Full Text] [Related]
7. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.
Kotlarz D; Beier R; Murugan D; Diestelhorst J; Jensen O; Boztug K; Pfeifer D; Kreipe H; Pfister ED; Baumann U; Puchalka J; Bohne J; Egritas O; Dalgic B; Kolho KL; Sauerbrey A; Buderus S; Güngör T; Enninger A; Koda YK; Guariso G; Weiss B; Corbacioglu S; Socha P; Uslu N; Metin A; Wahbeh GT; Husain K; Ramadan D; Al-Herz W; Grimbacher B; Sauer M; Sykora KW; Koletzko S; Klein C
Gastroenterology; 2012 Aug; 143(2):347-55. PubMed ID: 22549091
[TBL] [Abstract][Full Text] [Related]
8. Very early-onset inflammatory bowel disease (IBD) in infancy is a different disease entity from adult-onset IBD; one form of interleukin-10 receptor mutations.
Shim JO; Seo JK
J Hum Genet; 2014 Jun; 59(6):337-41. PubMed ID: 24785691
[TBL] [Abstract][Full Text] [Related]
9. [Interleukin-10 receptor mutations in children with neonatal onset inflammatory bowel disease: genetic diagnosis and pathogenesis].
Lu D; Xu Y; Chen Y; Zeng P; Chen H; Zeng H
Zhonghua Er Ke Za Zhi; 2015 May; 53(5):348-54. PubMed ID: 26080664
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: a survey of the Genius Working Group.
Pigneur B; Escher J; Elawad M; Lima R; Buderus S; Kierkus J; Guariso G; Canioni D; Lambot K; Talbotec C; Shah N; Begue B; Rieux-Laucat F; Goulet O; Cerf-Bensussan N; Neven B; Ruemmele FM
Inflamm Bowel Dis; 2013 Dec; 19(13):2820-8. PubMed ID: 24216686
[TBL] [Abstract][Full Text] [Related]
11. A novel biallelic 19-bp deletion in the IL10RB gene caused infant-onset inflammatory bowel disease in a consanguineous family: a molecular docking simulation study and literature review.
Motallebi F; Al Sudani ZM; Vaghefi F; Khosravi T; Rahimzadeh A; Kowsari A; Oladnabi M
Mol Biol Rep; 2024 Jan; 51(1):223. PubMed ID: 38281300
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.
Glocker EO; Kotlarz D; Boztug K; Gertz EM; Schäffer AA; Noyan F; Perro M; Diestelhorst J; Allroth A; Murugan D; Hätscher N; Pfeifer D; Sykora KW; Sauer M; Kreipe H; Lacher M; Nustede R; Woellner C; Baumann U; Salzer U; Koletzko S; Shah N; Segal AW; Sauerbrey A; Buderus S; Snapper SB; Grimbacher B; Klein C
N Engl J Med; 2009 Nov; 361(21):2033-45. PubMed ID: 19890111
[TBL] [Abstract][Full Text] [Related]
13. Autosomal recessive 333 base pair interleukin 10 receptor alpha subunit deletion in very early-onset inflammatory bowel disease.
Lv JJ; Su W; Chen XY; Yu Y; Xu X; Xu CD; Deng X; Huang JB; Wang XQ; Xiao Y
World J Gastroenterol; 2021 Nov; 27(44):7705-7715. PubMed ID: 34908808
[TBL] [Abstract][Full Text] [Related]
14. The clinical, molecular, and therapeutic features of patients with IL10/IL10R deficiency: a systematic review.
Sharifinejad N; Zaki-Dizaji M; Sepahvandi R; Fayyaz F; Dos Santos Vilela MM; ElGhazali G; Abolhassani H; Ochs HD; Azizi G
Clin Exp Immunol; 2022 Jun; 208(3):281-291. PubMed ID: 35481870
[TBL] [Abstract][Full Text] [Related]
15. Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation.
Murugan D; Albert MH; Langemeier J; Bohne J; Puchalka J; Järvinen PM; Hauck F; Klenk AK; Prell C; Schatz S; Diestelhorst J; Sciskala B; Kohistani N; Belohradsky BH; Müller S; Kirchner T; Walter MR; Bufler P; Muise AM; Snapper SB; Koletzko S; Klein C; Kotlarz D
J Clin Immunol; 2014 Apr; 34(3):331-9. PubMed ID: 24519095
[TBL] [Abstract][Full Text] [Related]
16. [Interleukin-10 receptor gene mutations induced very early onset inflammatory bowel disease in 6 infants].
Wang FP; Ma X; Zhu D; Gong YZ; Ning HJ; Zhong XM
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):753-758. PubMed ID: 30293279
[No Abstract] [Full Text] [Related]
17. [Clinical and genotypic characteristics of infantile inflammatory bowel disease].
Gong YZ; Ning HJ; Ma X; Zhu D; Wang FP; Zhang R; Zhang YL; Zhong XM
Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):520-525. PubMed ID: 31269551
[No Abstract] [Full Text] [Related]
18. Genetic profile of patients with early onset inflammatory bowel disease.
Girardelli M; Basaldella F; Paolera SD; Vuch J; Tommasini A; Martelossi S; Crovella S; Bianco AM
Gene; 2018 Mar; 645():18-29. PubMed ID: 29248579
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Mutation Description of the First Iranian Cohort of Infantile Inflammatory Bowel Disease: The Iranian Primary Immunodeficiency Registry (IPIDR).
Rahmani F; Rayzan E; Rahmani MR; Shahkarami S; Zoghi S; Rezaei A; Aryan Z; Najafi M; Rohlfs M; Jeske T; Aflatoonian M; Chavoshzadeh Z; Farahmand F; Motamed F; Rohani P; Alimadadi H; Mahdaviani A; Mansouri M; Tavakol M; Vanderberg M; Kotlarz D; Klein C; Rezaei N
Immunol Invest; 2021 May; 50(4):445-459. PubMed ID: 32633164
[TBL] [Abstract][Full Text] [Related]
20. Restored Macrophage Function Ameliorates Disease Pathophysiology in a Mouse Model for IL10 Receptor-deficient Very Early Onset Inflammatory Bowel Disease.
Ackermann M; Mucci A; McCabe A; Frei S; Wright K; Snapper SB; Lachmann N; Williams DA; Brendel C
J Crohns Colitis; 2021 Sep; 15(9):1588-1595. PubMed ID: 33596307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
